Product Categories
Country: | United States |
---|---|
Tel: | 1-631-485-4226 |
Mobile: | 16314854226 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
(±)-Epibatidine dihydrochloride | C11H15Cl3N2 | 162885-01-0 | Details |
(±)9-HpODE | C18H32O4 | 5502-91-0 | Details |
(±)10(11)-EDP Ethanolamide | C24H37NO3 | 2123484-71-7 | Details |
(±)5(6)-EET Ethanolamide | Details |
(±)-Epibatidine | C11H13ClN2 | 148152-66-3 | Details |
(+)-U-50488 mesylate | C18H25Cl3N2O | 107902-84-1 | Details |
(±)11(12)-EET | C20H32O3 | 123931-40-8 | Details |
(+/-)-alpha-Lipoamide | C8H15NOS2 | 940-69-2 | Details |
(±)2-(14,15-Epoxyeicosatrienoyl) Glycerol | C23H38O5 | 848667-56-1 | Details |
(±)-Niguldipine hydrochloride | C36H40ClN3O6 | 119934-51-9 | Details |
(±)-Fabesetron hydrochloride | C18H20ClN3O | 129299-81-6 | Details |
(±)8(9)-EET methyl ester | C21H34O3 | Details |
(±)5-HETE lactone | C20H30O2 | 73279-37-5 | Details |
(±)-Equol | C15H14O3 | 94105-90-5 | Details |
(±)17(18)-EpETE-Ethanolamide | C22H35NO3 | 2123491-23-4 | Details |
(±)16-HETE | C20H32O3 | 128914-46-5 | Details |
(±)17(18)-EpETE | C20H30O3 | Details |
(±)-AMG 487 | C32H28F3N5O4 | 947536-03-0 | Details |
(±)-5'-Chloro-5'-deoxy-ENBA | C17H22ClN5O3 | 103626-26-2 | Details |
(±)-Amiflamine | C12H20N2 | 77502-96-6 | Details |
(±)-BI-D | C25H27NO4 | 1416258-16-6 | Details |
(±)5(6)-DiHET | C20H34O4 | 213382-49-1 | Details |
(±)-Huperzine A | C15H18N2O | 120786-18-7 | Details |
(±)-Nipecotic acid | C6H11NO2 | 60252-41-7 | Details |
(±)8(9)-EET | C20H32O3 | Details |
(±)-Evodiamine | C19H17N3O | 518-18-3 | Details |
(±)17-HETE | C20H32O3 | 128914-47-6 | Details |
(+)-U 50488 | C19H26Cl2N2O | 67198-17-8 | Details |
(3S,5S)-Atorvastatin sodium salt | C33H36FN2NaO5 | 1428118-38-0 | Details |
(2R,3'R)-Glycopyrrolate Bromide | C19H28NO3.Br | 475468-09-8 | Details |
(E/Z)-BIO-acetoxime | C18H12BrN3O3 | 740841-15-0 | Details |
(2R,3S)-E1R | C13H16N2O2 | 1424832-60-9 | Details |
(1α,1'S,4β)-Lanabecestat | C26H28N4O | 1384082-96-5 | Details |
(24S)-24,25-Dihydroxyvitamin D3 | C27H44O3 | 55700-58-8 | Details |
(E/Z)-IT-603 | C11H9BrN2O3S | 292168-90-2 | Details |
(Glp1)-Apelin-13 trifluoroacetate salt | Details |
(1S,3S)-ACPD | C7H11NO4 | 111900-31-3 | Details |
(E)-4-Hydroxytamoxifen | C26H29NO2 | 174592-47-3 | Details |
(1E)-CFI-400437 dihydrochloride | C29H29ClN6O2 | 1247000-76-5 | Details |
(2R,5S)-Ritlecitinib | C15H19N5O | 1792180-79-0 | Details |
(7R)-3-Bromo-2,5-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-methanamine | C11H14BrNO2 | 912440-88-1 | Details |
(2Z)-LFM-A13 | C11H8Br2N2O2 | 244240-24-2 | Details |
(5S,8R)-HBV-IN-10 | C23H24FN7O | 2716907-15-0 | Details |
(Hyp3)-Bradykinin acetate | Details |
(E)-Tetrachlorvinphos | C10H9Cl4O4P | 22350-76-1 | Details |
(beta)-Estradiol 17-acetate | C20H26O3 | 1743-60-8 | Details |
(±)-N-Methylduloxetine hydrochloride | C19H22ClNOS | 916135-70-1 | Details |
(2R,βS)-GC376 | Details |
(Ala1)-PAR4 (1-6) (mouse) trifluoroacetate salt | Details |
(E/Z)-BCI | C22H23NO | 15982-84-0 | Details |
(2R)-TAPI-1 | C26H37N5O5 | 163847-77-6 | Details |
(2R/S)-6-PNG | C20H20O5 | 68682-01-9 | Details |
(2R,βR)-GC376 | Details |
(R)-(+)-8-Hydroxy-DPAT | C16H25NO | 80300-09-0 | Details |
(R)-5-Methoxy-N-propyl-2-aminotetraline hydrochloride | C14H22ClNO | 93601-85-5 | Details |
(Ala1)-PAR4 (1-6) amide (mouse) trifluoroacetate salt | Details |
(R)-6-Hydroxybuspirone | C21H31N5O3 | 477930-30-6 | Details |
(E)-[6]-Dehydroparadol | C17H24O3 | 878006-06-5 | Details |
(2S)-OMPT (ammonium salt) | C22H43O6PS | 645408-61-3 | Details |
(E/Z)-Sivopixant | C25H22ClN5O5 | 1640808-39-4 | Details |
(5Z,2E)-CU-3 | C16H12N2O4S3 | 1815598-71-0 | Details |
(9R,10R)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene | Details |
(R)-(+)-Tolterodine | C22H31NO | 124937-51-5 | Details |
(2R,3R)-E1R | C13H16N2O2 | 1400888-63-2 | Details |
(E)-PAC-1 | C23H28N4O2 | 1044929-62-5 | Details |
(10S)-Methyllycaconitine citrate | C43H58N2O17 | 351344-10-0 | Details |
(2S)-2-Hydroxyglutaric acid | C5H8O5 | 13095-48-2 | Details |
(32-Carbonyl)-RMC-5552 | C93H134N10O24 | 2382768-55-8 | Details |
(E)-Nitrofural | C6H6N4O4 | 112574-44-4 | Details |
(2S,3R)-Voruciclib | C22H19ClF3NO5 | 1253731-24-6 | Details |
(2S,3R)-Voruciclib hydrochloride | Details |
(E)-RPL-554 | C26H31N5O4 | 1884461-72-6 | Details |
(R)-(-)-Rolipram | C16H21NO3 | 85416-75-7 | Details |
(3R,4R)-A2-32-01 | C19H27NO2 | 1359752-95-6 | Details |
(E/Z)-GO289 | C17H15BrN4O2S | 694522-87-7 | Details |
(2S)-2-[(6,8-Difluoro-1,2,3,4-tetrahydro-2-naphthalenyl)amino]-N-[1-[2-[(2,2-dimethylpropyl)amino]-1,1-dimethylethyl]-1H-imidazol-4-yl]pentanamide | C27H41F2N5O | 865773-15-5 | Details |
(R)-(-)-N-Desmethyl-PK 11195 | C20H19ClN2O | 157809-85-3 | Details |
(E/Z)-GSK-3β inhibitor 1 | C14H10N2O | 3367-88-2 | Details |
(Lys8,Lys9)-Neurotensin (8-13) | C38H64N8O8 | 139026-64-5 | Details |
(2S)-4-biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide | C18H21NO4S | 1354546-42-1 | Details |
(E/Z)-GSK5182 | C27H31NO3 | 2699724-40-6 | Details |
(R)-(+)-Nor Verapamil Hydrochloride | C26H36N2O4 | 123932-43-4 | Details |
(E)-4-Hydroxy-N-desmethyl tamoxifen | C25H27NO2 | 114828-90-9 | Details |
(E)-SIS3 | C28H27N3O3 | 521985-36-4 | Details |
(R)-5-Hydroxymethyl tolterodine | C22H31NO2 | 207679-81-0 | Details |
(2S,3S)-E1R | C13H16N2O2 | 1424832-57-4 | Details |
(E)-3,4-Dihydroxybenzylideneacetone | C10H10O3 | 123694-03-1 | Details |
(R)-3-Hydroxy Midostaurin | C35H30N4O5 | 155848-20-7 | Details |
(E)-5-((4-(((Carboxymethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid | C16H13N3O6 | 80573-03-1 | Details |
(E/Z)-AG490 | C17H14N2O3 | 134036-52-5 | Details |
(E)-Akt inhibitor-IV | C31H27IN4S | 959841-49-7 | Details |
(E/Z)-Trelnarizine Hydrochloride | C28H32Cl2F2N2O2 | 99661-27-5 | Details |
(R)-(-)-Niguldipine Hydrochloride | C36H40ClN3O6 | 113145-70-3 | Details |
(1S,3R,5R)-PIM447 dihydrochloride | C??H??Cl?F?N?O | Details |
(2-Chloropyridin-4-yl)methanamine hydrochloride | C6H8Cl2N2 | 916210-98-5 | Details |
(±)-Salsolinol hydrochloride | C10H14ClNO2 | 79923-51-6 | Details |
(D)-PPA 1 | C70H98N20O21 | 1620813-53-7 | Details |
(E)-GABAB receptor antagonist 1 | C18H24O4 | 1611483-29-4 | Details |
(25S)-Δ7-Dafachronic acid | C27H42O3 | 949004-12-0 | Details |
Product Total: Product Page: | ||||
82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 |